HYPOFIBRINOGENAEMIA

This adverse event was reported 0 times

These drugs are most commonly taken by patients reporting HYPOFIBRINOGENAEMIA:

# Drug Count
0 METHOTREXATE SODIUM 239
1 PEGASPARGASE 236
2 METHOTREXATE 228
3 CYTARABINE 120
4 DEXAMETHASONE 117
5 DEXAMETHASONE 1.5 MG 116
6 ANTI-ITCH 109
7 ANTI-ITCH CREAM 109
8 ANTI-PRURITIC 109
9 ANTIPRURITIC (ANTI-ITCH) 109
See all common drugs associated with HYPOFIBRINOGENAEMIA

HYPOFIBRINOGENAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEGASPARGASE 236 0.0402
1 NALBUPHINE HYDROCHLORIDE 2 0.0253
2 RASBURICASE 18 0.0205
3 TIGECYCLINE 38 0.0148
4 OYSTER SHELL CALCIUM WITH VITAMIN D 1 0.0096
5 TENECTEPLASE 3 0.0060
6 PURIXAN 2 0.0054
7 VINCRISTINE SULFATE 52 0.0049
8 CYTARABINE 120 0.0048
9 ANTI-ITCH CREAM 109 0.0044
See all drugs enriched for association with HYPOFIBRINOGENAEMIA

HYPOFIBRINOGENAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anti-coagulant [EPC] 4 0.0043
1 Human Serum Albumin [EPC] 2 0.0010
2 Tetracycline-class Drug [EPC] 1 0.0000
3 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
4 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
5 Insulin Analog [EPC] 1 0.0000
See all drug classes enriched for association with HYPOFIBRINOGENAEMIA